ABSCINT
ABSCINT is a clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies.
ABSCINT
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2022-01-01
Address:
Ganshoren, Brussels Hoofdstedelijk Gewest, Belgium
Country:
Belgium
Website Url:
http://www.abscint.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Investors List
Vrije Universiteit Brussel
Vrije Universiteit Brussel investment in Seed Round - Abscint
Qbic Fund
Qbic Fund investment in Seed Round - Abscint
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Seed Round - Abscint
Official Site Inspections
http://www.abscint.com
- Host name: 188.208.36.239.static.hosted.by.combell-ops.net
- IP address: 188.208.36.239
- Location: Belgium
- Latitude: 50.8509
- Longitude: 4.3447
- Timezone: Europe/Brussels
More informations about "Abscint"
Abscint - Crunchbase Company Profile & Funding
Abscint has 3 investors including Vrije Universiteit Brussel and Qbic Fund. When was the last funding round for Abscint? Abscint closed its last funding round on Feb 10, 2021 from a Seed …See details»
ABSCINT — About Us
At ABSCINT, our mission is to revolutionize HER2 cancer care by developing state-of-the-art in vivo imaging diagnostics. We are dedicated to leveraging the collective expertise of our …See details»
ABSCINT Company Profile 2024: Valuation, Funding & Investors
When was ABSCINT founded? ABSCINT was founded in 2020. Where is ABSCINT headquartered? ABSCINT is headquartered in Ganshoren, Belgium. What is the size of …See details»
ABSCINT - LinkedIn
ABSCINT | 1,142 followers on LinkedIn. ABSCINT, Harnessing Antibody Scintigraphy for Precision Diagnostics in Breast Cancer and Beyond | ABSCINT specializes in advanced in …See details»
Abscint - Products, Competitors, Financials, Employees, …
Dec 5, 2022 About Abscint. Abscint is a clinical-stage company focused on in vivo imaging diagnostics within the healthcare sector. The company specializes in developing innovative …See details»
Abscint - Funding, Financials, Valuation & Investors - Crunchbase
Feb 10, 2021 ABSCINT is a clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies. Search Crunchbase. Start Free Trial . ... How …See details»
Abscint - Contacts, Employees, Board Members, Advisors & Alumni
ABSCINT is a clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies.See details»
Abscint | VentureRadar
ABSCINT focuses on the development of radiolabelled single domain antibodies for whole body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, for …See details»
ABSCINT - VUB TechTransfer
Abscint NV. Broustinlaan 67. 1083 Brussels. Belgium [E] [email protected] . Go to website. VUB TechTransfer . Pleinlaan 11, 1050 Brussels - Belgium + 32 2 614 88 00. …See details»
ABSCINT | Rad4Med
ABSCINT focuses on the development of radiolabelled single domain antibodies for whole body molecular imaging applications, to be used for the diagnosis of disease, for molecular …See details»
ABSCINT — Our Challenge
ABSCINT is pioneering the development of next-generation in vivo imaging diagnostic tools to enhance patient care, from the selection of the optimal treatment strategy to comprehensive …See details»
Abscint - Crunchbase
ABSCINT is a clinical stage molecular imaging company developing in-vivo diagnostics based on single domain antibodies.See details»
Qbic II leads seed round in Abscint
A new VUB spin-off named ABSCINT NV was established. The spin-off is based on technology developed by the joint research efforts of the teams of Prof. Dr. Tony Lahoutte and Prof. Dr. Jo …See details»
Abscint - Qbic
ABSCINT´s story started in the laboratory of Prof. Tony Lahoutte, Chief of the Nuclear Medicine department at University Hospital Brussels and head of the VUB´s Molecular Imaging …See details»
Karine Clauwaert — ABSCINT
I love to cook for family and friends in my spare time; I swim and run to keep in shapeSee details»
Abscint - VentureRadar
Similar Companies: Commit Biologics Denmark Privately Held Commit Biologics is a biotechnology company focused on developing a novel platform technology to utilize the …See details»
ABSCINT — Patients
Sponsored by ABSCINT, the HERMIA trial is testing a new PET /CT scan method using a diagnostic product called 68 Ga-ABS011. This scan can show HER2 levels throughout the …See details»
ABSCINT — Our Results
Metastatic breast cancer patient initially diagnosed with HER2-low disease (IHC 1+) but progressing to HER2-positive (IHC 3+)See details»
ABSCINT — Press Releases
Dec 5, 2022 ABSCINT and the VUB announce a Notice of Allowance for their U.S. Patent covering diagnostic applications of its single-domain antibody labelled with radioisotopes for …See details»